GlassScriptPhysician profile
Nishant Gupta
NPI 1366609620
$144,929.99
in general payments reported to CMS, 2019-2025
41 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $43K · 2021: $31K · 2022: $8,637 · 2023: $9,080 · 2024: $9,680 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $7,503 · Travel and Lodging: $3,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,498.75 |
| Food and Beverage | $7,503.13 |
| Travel and Lodging | $3,248.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $68,341.37 | 2019-2020 | |
| Medtronic, INC. | $63,527.53 | 2021-2025 | Corevalve Evolut R, Micra, Abre |
| Abbott Laboratories | $4,117.72 | 2019-2025 | Triclip, Portico, Tacticath Ablation Catheter, Sensor Enabled |
| Abiomed | $1,543.69 | 2019-2025 | Impella |
| Biosense Webster, INC. | $1,210.32 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Boston Scientific Corporation | $1,126.35 | 2019-2025 | Watchman Flx, General - Therapies, Rotapro |
| Edwards Lifesciences Corporation | $729.44 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $612.42 | 2022-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $514.25 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $315.76 | 2023-2025 | Assure Wcd |
| Chiesi USA, INC. | $275.15 | 2019-2025 | Kengreal, Cleviprex |
| Amgen INC. | $239.14 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $225.53 | 2019-2024 | |
| Angiodynamics, INC. | $222.15 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $195.33 | 2019-2025 | Wainua |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.